Physician profile
Thomas Nuttli
NPI 1356310783
$9,296.10
in general payments reported to CMS, 2019-2025
34 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $877 · 2020: $729 · 2021: $1,052 · 2022: $1,470 · 2023: $1,839 · 2024: $1,242 · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,167.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,416.02 | 2019-2025 | Tezspire, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $2,398.00 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $822.16 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $574.73 | 2020-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $437.35 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $340.51 | 2020-2025 | |
| Grifols USA, LLC | $298.72 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $263.40 | 2020-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $174.54 | 2023-2025 | Winrevair |
| Baxter Healthcare | $140.24 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $137.71 | 2019-2023 | Tyvaso |
| Janssen Pharmaceuticals, INC | $137.04 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.68 | 2021-2023 | |
| Amgen INC. | $104.20 | 2022-2024 | Tezspire |
| Viatris Specialty LLC | $97.99 | 2025 | Yupelri |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $95.05 | 2019-2025 | Arikayce, Brinsupri |
| Paratek Pharmaceuticals, INC. | $91.21 | 2022-2025 | Nuzyra |
| Inogen, INC. | $90.51 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genentech USA, INC. | $74.85 | 2019 | |
| Ethicon INC. | $72.97 | 2022 | |
| Electromed, INC. | $64.05 | 2024-2025 | Smartvest |
| Philips North America LLC | $62.99 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.75 | 2019-2024 | Eliquis |
| Verona Pharma, INC. | $39.82 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $30.11 | 2024 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Ambu INC. | $25.08 | 2022 | |
| Inari Medical, INC. | $24.49 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Gilead Sciences, INC. | $24.25 | 2021 | |
| Vifor Pharma, INC. | $19.65 | 2025 | Veltassa |
| Pfizer INC. | $16.35 | 2025 | |
| Lilly USA, LLC | $16.21 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $16.20 | 2020 | |
| Csl Behring | $13.30 | 2019 | |
| Circassia INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nuttli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.